Rosa Valenzuela, CEO of Innomedyx, has recently signed a collaboration agreement with Harmonium innovation, international company with innovative and breakthrought products and projects. With this alliance, both institutions will participate in the selection and development of projects that are focused on the prevention and treatment of diabetes.
Innomedyx, Center of Translational Research in Medicine, aims to promote the interaction between basic research and the applied clinic. Therefore, it will select projects through the universities and research centers with which Innomedyx will work in the future. Harmonium, for its part, will invest in the translation of them with the objective of incorporating them into their portfolio of products and services.
Innomedyx and Harmonium will lead this partnership into development, innovation and commercialization of solutions that will help in the control, treatment and prevention of diabetes.